Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Glaucoma, Suspect

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Glaucoma, Suspect in 2 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
May, JA1
McLaughlin, MA1
Sharif, NA1
Hellberg, MR1
Dean, TR1
Chu, TC1
Ogidigben, MJ1
Potter, DE1

Other Studies

2 other studies available for 8-hydroxy-2-(di-n-propylamino)tetralin and Glaucoma, Suspect

ArticleYear
Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 306, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; CHO Cells; Cricetinae; Disease Models, Animal; Enzy

2003
8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action.
    Experimental eye research, 1999, Volume: 69, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Ciliary Body; Cyclic AMP; Dioxanes; Dopamine Antago

1999